» Articles » PMID: 25071870

The Role of Antiproliferative Gene Tob1 in the Immune System

Overview
Specialty Neurology
Date 2014 Jul 30
PMID 25071870
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Tob1 (transducer of ERBB2-1, TOB1 is humans) is a member of the antiproliferative (APRO) family of proteins that controls cell cycle progression in several cell types. In addition, Tob1 has been implicated in diverse cellular mechanisms such as embryonic dorsal development, and T helper 17 (Th17) cell function. More recently, evidence linking Tob1 function to experimental and human immune related disorders has mounted, thus underscoring the potential of this molecule as a biomarker and as a therapeutic target. This article reviews these functions with an emphasis on their implications for human autoimmune diseases such as multiple sclerosis.

Citing Articles

Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints.

Dulal D, Boring A, Terrero D, Johnson T, Tiwari A, Raman D Cancers (Basel). 2023; 15(10).

PMID: 37345111 PMC: 10216651. DOI: 10.3390/cancers15102774.


Multi-Transcript Level Profiling Revealed Distinct mRNA, miRNA, and tRNA-Derived Fragment Bio-Signatures for Coping Behavior Linked Haplotypes in HPA Axis and Limbic System.

Gley K, Hadlich F, Trakooljul N, Haack F, Murani E, Gimsa U Front Genet. 2021; 12:635794.

PMID: 34490028 PMC: 8417057. DOI: 10.3389/fgene.2021.635794.


Antigen presentation between T cells drives Th17 polarization under conditions of limiting antigen.

Boccasavia V, Bovolenta E, Villanueva A, Borroto A, Oeste C, van Santen H Cell Rep. 2021; 34(11):108861.

PMID: 33730591 PMC: 7972993. DOI: 10.1016/j.celrep.2021.108861.


Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis.

Kim K, Probstel A, Baumann R, Dyckow J, Landefeld J, Kogl E Brain. 2020; 144(2):450-461.

PMID: 33374005 PMC: 8491073. DOI: 10.1093/brain/awaa421.


Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.

ElTanbouly M, Noelle R Nat Rev Immunol. 2020; 21(4):257-267.

PMID: 33077935 DOI: 10.1038/s41577-020-00454-2.


References
1.
Underwood R, Chiravuri M, Lee H, Schmitz T, Kabcenell A, Yardley K . Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase. J Biol Chem. 1999; 274(48):34053-8. DOI: 10.1074/jbc.274.48.34053. View

2.
Bista P, Mele D, Baez D, Huber B . Lymphocyte quiescence factor Dpp2 is transcriptionally activated by KLF2 and TOB1. Mol Immunol. 2008; 45(13):3618-23. PMC: 2597389. DOI: 10.1016/j.molimm.2008.05.001. View

3.
Corvol J, Pelletier D, Henry R, Caillier S, Wang J, Pappas D . Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event. Proc Natl Acad Sci U S A. 2008; 105(33):11839-44. PMC: 2504481. DOI: 10.1073/pnas.0805065105. View

4.
Bliss T, Collingridge G . A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993; 361(6407):31-9. DOI: 10.1038/361031a0. View

5.
Chiravuri M, Schmitz T, Yardley K, Underwood R, DAYAL Y, Huber B . A novel apoptotic pathway in quiescent lymphocytes identified by inhibition of a post-proline cleaving aminodipeptidase: a candidate target protease, quiescent cell proline dipeptidase. J Immunol. 1999; 163(6):3092-9. View